Dr. Jishu Shi spoke to SEEK magazine to talk about how his team developed a safe and efficacious protein vaccine to protect swine against classical swine fever. To read more about this, click here and go to pages 17-18. Futhermore, page 22 describes how vaccines are developed and what is a vaccine adjuvant.
Dr. Jishu Shi unpacks the potential cause and impact of at least two new strains of African Swine Fever (ASF) virus, which were remarkable for the absence of particular genes.
An excerpt from the Feedinfo article follows:
Dr. Shi is definitely sympathetic to the enormous strain being put on producers in regions challenged by ASF. “In a desperate situation, a lot of people would rather have something [to help them minimize the threat of ASF for their farms],” he acknowledges. Those who might have turned to illicit vaccines “didn’t know it was poison, that it would cause more damage than the relief they hoped for.”
Click here to read the full story.
For those who are curious about the contributing factors behind the global successes and failures in the prevention and control of swine fevers—classical swine fever (CSF) and African swine fever (ASF), Jishu Shi addresses this hot topic head-on in Animal Frontiers.
To learn the key takeaways, please read “Of pigs and men: the best-laid plans for prevention and control of swine fevers” — the first feature in Animal Frontiers’ Volume 11, Issue 1.